NCT06938880View on ClinicalTrials.gov

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

April 30, 2028

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

ZGGS18 for Injection

Intravenous infusion

BIOLOGICAL

ZG005 for Injection

Intravenous infusion

Trial Locations (1)

Unknown

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY